- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03112811
Influence of Techniques of Chest Physiotherapy in the Pediatric Intensive Care
April 7, 2017 updated by: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Influence of Techniques of Chest Physiotherapy on the Respiratory Status and the Hemodynamic Impact in the Pediatric Intensive Care
The purpose of this study is to compare the effect of the autogenic drainage and the intrapulmonary percussive ventilation on the levying of the lung atelectasis, by means of the thoracic imaging (thoracic ultrasound and radiography), at the intubated or extubated child with the ventilatory support.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bruxelles, Belgium
- Recruiting
-
Contact:
- Damien M Moerman, PT
- Email: damien.moerman@uclouvain.be
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 16 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Child < 10 kg
- Hospitalization in the pediatric intensive care
- Presence of an atelectasis to the radiography and/or to the lung ultrasound
- Presence of an invasive ventilation or a non-invasive ventilation
- Criteria of cardio-respiratory stability met
Exclusion Criteria:
- Absence of the physiotherapist and the radiologist referents (by ex: at night)
- Prematurity
- Neuromuscular disease
- Ventilation by high-frequency oscillation
- Extraphysical Assistance
- Patient cardiac post-surgery with closure postponed from the thorax. In the closure of the thorax, the patient becomes eligible
- Intracranial pressure > 20 mmHg or clinical signs of intracranial high blood pressure
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intubated infant
|
The manual technique of the chest physiotherapy to move the secretions
The instrumental technique of the chest physiotherapy to move the secretions
|
|
Experimental: Extubated infant
|
The manual technique of the chest physiotherapy to move the secretions
The instrumental technique of the chest physiotherapy to move the secretions
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline Atelectasis scores at 20 min
Time Frame: Baseline and at 20 min
|
Each atelectasis has a thoracic ultrasound
|
Baseline and at 20 min
|
|
Change from baseline cardiac frequency at 20 min, 30 min, 50 min, 80 min
Time Frame: Baseline and at 20 min, 30 min, 50 min, 80 min
|
Stability of the parameters
|
Baseline and at 20 min, 30 min, 50 min, 80 min
|
|
Change from baseline respiratory frequency at 20 min, 30 min, 50 min, 80 min
Time Frame: Baseline and at 20 min, 30 min, 50 min, 80 min
|
Stability of the parameters
|
Baseline and at 20 min, 30 min, 50 min, 80 min
|
|
Change from baseline systolic blood pressure at 20 min, 30 min, 50 min, 80 min
Time Frame: Baseline and at 20 min, 30 min, 50 min, 80 min
|
Stability of the parameters
|
Baseline and at 20 min, 30 min, 50 min, 80 min
|
|
Change from baseline diastolic blood pressure at 20 min, 30 min, 50 min, 80 min
Time Frame: Baseline and at 20 min, 30 min, 50 min, 80 min
|
Stability of the parameters
|
Baseline and at 20 min, 30 min, 50 min, 80 min
|
|
Change from baseline oxygen saturation at 20 min, 30 min, 50 min, 80 min
Time Frame: Baseline and at 20 min, 30 min, 50 min, 80 min
|
Stability of the parameters
|
Baseline and at 20 min, 30 min, 50 min, 80 min
|
|
Change from baseline expiratory CO2 at 20 min, 30 min, 50 min, 80 min
Time Frame: Baseline and at 20 min, 30 min, 50 min, 80 min
|
Stability of the parameters
|
Baseline and at 20 min, 30 min, 50 min, 80 min
|
|
Compare the atelectasis scores
Time Frame: Baseline between thoracic ultrasound and chest x-ray
|
Compare the atelectasis scores between thoracic ultrasound and chest x-ray
|
Baseline between thoracic ultrasound and chest x-ray
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of unexpected events
Time Frame: At 20 min
|
Pain, desaturation, accidentally extubation
|
At 20 min
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 3, 2007
Primary Completion (Anticipated)
December 31, 2020
Study Completion (Anticipated)
January 1, 2021
Study Registration Dates
First Submitted
April 3, 2017
First Submitted That Met QC Criteria
April 7, 2017
First Posted (Actual)
April 13, 2017
Study Record Updates
Last Update Posted (Actual)
April 13, 2017
Last Update Submitted That Met QC Criteria
April 7, 2017
Last Verified
April 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Atelectasis001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Atelectasis
-
Seoul National University HospitalCompletedPulmonary Atelectasis, Postoperative | Atelectasis, CompressionKorea, Republic of
-
Capital Medical UniversityRecruiting
-
Menoufia UniversityCompleted
-
Xuzhou Medical UniversityCompleted
-
Severance HospitalCompletedAtelectasis, PostoperativeKorea, Republic of
-
Vittore Buzzi Children's HospitalNot yet recruiting
-
Ankara Etlik City HospitalActive, not recruiting
-
Emory UniversityPEEP Medical, LLCCompletedPostoperative AtelectasisUnited States
-
Marmara UniversityCompleted
-
Mansoura UniversityEnrolling by invitationAnesthesia Induced AtelectasisEgypt
Clinical Trials on Autogenic drainage
-
Cliniques universitaires Saint-Luc- Université...Completed
-
Cairo UniversityPrincess Nourah Bint Abdulrahman UniversityCompletedPostoperative ComplicationsEgypt
-
Cliniques universitaires Saint-Luc- Université...Completed
-
Universidad San JorgeCystic Fibrosis FoundationCompletedCystic FibrosisSpain
-
Association Nationale pour les Traitements A Domicile...Completed
-
Riphah International UniversityCompletedPneumonia ChildhoodPakistan
-
Cliniques universitaires Saint-Luc- Université...Withdrawn
-
Carmel Medical CenterRambam Health Care CampusUnknownBronchiectasisIsrael
-
Riphah International UniversityRecruitingChronic Obstructive Pulmonary DiseasePakistan
-
Vrije Universiteit BrusselCompleted